标题
Harnessing type I interferon-mediated immunity to target malignant brain tumors
作者
关键词
-
出版物
Frontiers in Immunology
Volume 14, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2023-05-25
DOI
10.3389/fimmu.2023.1203929
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pro- vs. Anti-Inflammatory Features of Monocyte Subsets in Glioma Patients
- (2023) Natalia Lehman et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Single-cell spatial immune landscapes of primary and metastatic brain tumours
- (2023) Elham Karimi et al. NATURE
- Breaking down the cellular responses to type I interferon neurotoxicity in the brain
- (2023) Barney Viengkhou et al. Frontiers in Immunology
- Adjuvant Temozolomide Chemotherapy With or Without Interferon Alfa Among Patients With Newly Diagnosed High-grade Gliomas
- (2023) Chengcheng Guo et al. JAMA Network Open
- Transcriptome analysis reveals tumor microenvironment changes in glioblastoma
- (2023) Youri Hoogstrate et al. CANCER CELL
- Immune Functions of Astrocytes in Viral Neuroinfections
- (2023) Jernej Jorgačevski et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10
- (2022) Vidhya M. Ravi et al. Nature Communications
- Type I interferon-mediated tumor immunity and its role in immunotherapy
- (2022) Renren Yu et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Single-cell RNA sequencing reveals evolution of immune landscape during glioblastoma progression
- (2022) Alan T. Yeo et al. NATURE IMMUNOLOGY
- Type I interferon transcriptional network regulates expression of coinhibitory receptors in human T cells
- (2022) Tomokazu S. Sumida et al. NATURE IMMUNOLOGY
- Interferon‑α and its effects on cancer cell apoptosis (Review)
- (2022) Weiye Shi et al. Oncology Letters
- Infiltrating natural killer cells bind, lyse and increase chemotherapy efficacy in glioblastoma stem-like tumorospheres
- (2022) Barbara Breznik et al. Communications Biology
- Challenges in glioblastoma immunotherapy: mechanisms of resistance and therapeutic approaches to overcome them
- (2022) Karl John Habashy et al. BRITISH JOURNAL OF CANCER
- Understanding the relationship between gliomas and T cells: Paving the way for effective immunotherapy
- (2022) Catalina Lee-Chang NEURO-ONCOLOGY
- Targeted inducible delivery of immunoactivating cytokines reprograms glioblastoma microenvironment and inhibits growth in mouse models
- (2022) Filippo Birocchi et al. Science Translational Medicine
- Natural killer cell awakening: unleash cancer-immunity cycle against glioblastoma
- (2022) Minjie Wang et al. Cell Death & Disease
- Immunotherapy of glioblastoma explants induces interferon-γ responses and spatial immune cell rearrangements in tumor center, but not periphery
- (2022) Tala Shekarian et al. Science Advances
- Recent and future perspectives on engineering interferons and other cytokines as therapeutics
- (2022) Theint Aung et al. TRENDS IN BIOCHEMICAL SCIENCES
- Temporally restricted activation of IFNβ signaling underlies response to immune checkpoint therapy in mice
- (2022) Rachael M. Zemek et al. Nature Communications
- Blood monocyte-derived CD169+ macrophages contribute to antitumor immunity against glioblastoma
- (2022) Hyun-Jin Kim et al. Nature Communications
- Transcriptome Analysis Identifies Accumulation of Natural Killer Cells with Enhanced Lymphotoxin-β Expression during Glioblastoma Progression
- (2022) Gianni Monaco et al. Cancers
- Differential roles of type I interferon signaling in tumor versus host cells in experimental glioma models
- (2022) Evelina Blomberg et al. Translational Oncology
- Chronic type I interferon signaling promotes lipid-peroxidation-driven terminal CD8+ T cell exhaustion and curtails anti-PD-1 efficacy
- (2022) Weixin Chen et al. Cell Reports
- Cancer cell-derived type I interferons instruct tumor monocyte polarization
- (2022) Dylan Kwart et al. Cell Reports
- The Conventional Dendritic Cell 1 Subset Primes CD8+ T Cells and Traffics Tumor Antigen to Drive Antitumor Immunity in the Brain
- (2022) Jay A. Bowman-Kirigin et al. Cancer Immunology Research
- Dendritic cell vaccines improve the glioma microenvironment: Influence, challenges, and future directions
- (2022) Jing Zhou et al. Cancer Medicine
- Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma
- (2022) Linda M. Liau et al. JAMA Oncology
- Impact of CD4 T cells on intratumoral CD8 T-cell exhaustion and responsiveness to PD-1 blockade therapy in mouse brain tumors
- (2022) Saad M Khan et al. Journal for ImmunoTherapy of Cancer
- The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to developing treatment
- (2021) Asieh Emami Nejad et al. Cancer Cell International
- Interferons in cancer immunoediting: sculpting metastasis and immunotherapy response
- (2021) Michelle von Locquenghien et al. JOURNAL OF CLINICAL INVESTIGATION
- Interferon Receptor Trafficking and Signaling: Journey to the Cross Roads
- (2021) Natacha Zanin et al. Frontiers in Immunology
- Single-cell RNA sequencing reveals functional heterogeneity of glioma-associated brain macrophages
- (2021) Natalia Ochocka et al. Nature Communications
- Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer
- (2021) Amélie Cachot et al. Science Advances
- Type I and II Interferons in the Anti-Tumor Immune Response
- (2021) Sarah E. Fenton et al. Cancers
- The Role of Microglia in Glioblastoma
- (2021) Noelia Geribaldi-Doldán et al. Frontiers in Oncology
- Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas
- (2021) Zohreh Amoozgar et al. Nature Communications
- Immunomodulatory Effect of Microglia-Released Cytokines in Gliomas
- (2021) Marika Lanza et al. Brain Sciences
- Tumor-Associated Microglia and Macrophages in the Glioblastoma Microenvironment and Their Implications for Therapy
- (2021) Rikke Sick Andersen et al. Cancers
- The Yin and Yang of Type I IFNs in Cancer Promotion and Immune Activation
- (2021) Martina Musella et al. Biology-Basel
- Type I interferon activates MHC class I-dressed CD11b+ conventional dendritic cells to promote protective anti-tumor CD8+ T cell immunity
- (2021) Ellen Duong et al. IMMUNITY
- Multispecific targeting of glioblastoma with tumor microenvironment-responsive multifunctional engineered NK cells
- (2021) Jiao Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dendritic Cell Vaccination of Glioblastoma: Road to Success or Dead End
- (2021) Angeliki Datsi et al. Frontiers in Immunology
- Intrinsic Interferon Signaling Regulates the Cell Death and Mesenchymal Phenotype of Glioblastoma Stem Cells
- (2021) Sabbir Khan et al. Cancers
- Proliferating CD8+ T Cell Infiltrates Are Associated with Improved Survival in Glioblastoma
- (2021) Ileana S. Mauldin et al. Cells
- Single-Cell Transcriptomic Analysis Revealed a Critical Role of SPP1/CD44-Mediated Crosstalk Between Macrophages and Cancer Cells in Glioma
- (2021) Cong He et al. Frontiers in Cell and Developmental Biology
- Combining radiotherapy with interferons; back to the future
- (2020) R.S.A. Goedegebuure et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Interferon‑β sensitizes human glioblastoma cells to the cyclin‑dependent kinase inhibitor, TG02
- (2020) Birthe Lohmann et al. Oncology Letters
- Revisiting the role of CD4+ T cells in cancer immunotherapy—new insights into old paradigms
- (2020) Rong En Tay et al. CANCER GENE THERAPY
- Glioma stem-like cells evade interferon suppression through MBD3/NuRD complex–mediated STAT1 downregulation
- (2020) Xiaoyan Zhan et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Type I Interferon Receptor Signaling in Astrocytes Regulates Hippocampal Synaptic Plasticity and Cognitive Function of the Healthy CNS
- (2020) Shirin Hosseini et al. Cell Reports
- Characterization of Hypoxia Signature to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Glioma Groups
- (2020) Wanzun Lin et al. Frontiers in Oncology
- Novel insights into astrocyte-mediated signaling of proliferation, invasion and tumor immune microenvironment in glioblastoma
- (2020) Hao Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- The Role of NK Cells and Innate Lymphoid Cells in Brain Cancer
- (2020) Alexander James Sedgwick et al. Frontiers in Immunology
- Cytotoxic CD8+ T cells in cancer and cancer immunotherapy
- (2020) Hans Raskov et al. BRITISH JOURNAL OF CANCER
- Revisiting the PD-1 pathway
- (2020) Nikolaos Patsoukis et al. Science Advances
- Different T-cell subsets in glioblastoma multiforme and targeted immunotherapy
- (2020) Hongsheng Wang et al. CANCER LETTERS
- Engineering cytokines and cytokine circuits
- (2020) Aileen W. Li et al. SCIENCE
- Treatment Progress of Immune Checkpoint Blockade Therapy for Glioblastoma
- (2020) Na Zhang et al. Frontiers in Immunology
- Extracellular Vesicle-Mediated Bilateral Communication between Glioblastoma and Astrocytes
- (2020) Lisa Nieland et al. TRENDS IN NEUROSCIENCES
- Interferons α and β in cancer: therapeutic opportunities from new insights
- (2019) Ernest C. Borden NATURE REVIEWS DRUG DISCOVERY
- A Characterization of Dendritic Cells and Their Role in Immunotherapy in Glioblastoma: From Preclinical Studies to Clinical Trials
- (2019) Siddhartha Srivastava et al. Cancers
- Tumor-associated reactive astrocytes aid the evolution of immunosuppressive environment in glioblastoma
- (2019) Dieter Henrik Heiland et al. Nature Communications
- Examining Peripheral and Tumor Cellular Immunome in Patients With Cancer
- (2019) Eda K. Holl et al. Frontiers in Immunology
- Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade
- (2019) Joseph L. Benci et al. CELL
- Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade
- (2019) Nicolas Jacquelot et al. CELL RESEARCH
- Interferon target-gene expression and epigenomic signatures in health and disease
- (2019) Franck J. Barrat et al. NATURE IMMUNOLOGY
- Single-Cell Profiling Defines Transcriptomic Signatures Specific to Tumor-Reactive versus Virus-Responsive CD4+ T Cells
- (2019) Assaf Magen et al. Cell Reports
- Defective Dendritic Cell Cytotoxic Activity of High-Grade Glioma Patients' Results from the Low Expression of Membrane TNFα and Can Be Corrected In Vitro by Treatment with Recombinant IL-2 or Exogenic Double-Stranded DNA
- (2018) Tamara Tyrinova et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate
- (2018) Lukas Bunse et al. NATURE MEDICINE
- Current state of immunotherapy for glioblastoma
- (2018) Michael Lim et al. Nature Reviews Clinical Oncology
- Antitumor Benefits of Antiviral Immunity: An Underappreciated Aspect of Oncolytic Virotherapies
- (2018) Shashi Gujar et al. TRENDS IN IMMUNOLOGY
- Astrocytes, the rising stars of the glioblastoma microenvironment
- (2018) Mayra Brandao et al. GLIA
- Intratumoral IFN-α gene delivery reduces tumor-infiltrating regulatory T cells through the downregulation of tumor CCL17 expression
- (2018) Aya Hirata et al. CANCER GENE THERAPY
- Targeting IFNα to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistance
- (2018) Yong Liang et al. Nature Communications
- Regulation of type I interferon signaling in immunity and inflammation: A comprehensive review
- (2017) Kun Chen et al. JOURNAL OF AUTOIMMUNITY
- Intracranial AAV-IFN-β gene therapy eliminates invasive xenograft glioblastoma and improves survival in orthotopic syngeneic murine model
- (2017) Dwijit GuhaSarkar et al. Molecular Oncology
- Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy
- (2017) Ruan F.V. Medrano et al. Oncotarget
- Converting Lymphoma Cells into Potent Antigen-Presenting Cells for Interferon-Induced Tumor Regression
- (2017) Jing Liao et al. Cancer Immunology Research
- Type I Interferons and Natural Killer Cell Regulation in Cancer
- (2017) Lena Müller et al. Frontiers in Immunology
- Dendritic cell-based immunotherapy
- (2016) Rachel L Sabado et al. CELL RESEARCH
- Fine-tuning of type I IFN-signaling in microglia — implications for homeostasis, CNS autoimmunity and interferonopathies
- (2016) Tobias Goldmann et al. CURRENT OPINION IN NEUROBIOLOGY
- Cytotoxic CD4+ T cells are correlated with better prognosis in Han Chinese grade II and grade III glioma subjects and are suppressed by PD-1 signaling
- (2016) Jing Ge et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- The embryonic type of SPP1 transcriptional regulation is re-activated in glioblastoma
- (2016) Magdalena Kijewska et al. Oncotarget
- Suppression of Type I Interferon Signaling Overcomes Oncogene-Induced Senescence and Mediates Melanoma Development and Progression
- (2016) Yuliya V. Katlinskaya et al. Cell Reports
- Dendritic Cell–Based Vaccines that Utilize Myeloid Rather than Plasmacytoid Cells Offer a Superior Survival Advantage in Malignant Glioma
- (2015) Mahua Dey et al. JOURNAL OF IMMUNOLOGY
- Type I IFN gene delivery suppresses regulatory T cells within tumors
- (2014) H Hashimoto et al. CANCER GENE THERAPY
- Side Effects of Cytokines Approved for Therapy
- (2014) Brian A. Baldo DRUG SAFETY
- Type I Interferon Protects Antiviral CD8+ T Cells from NK Cell Cytotoxicity
- (2014) Haifeng C. Xu et al. IMMUNITY
- Type I Interferons Protect T Cells against NK Cell Attack Mediated by the Activating Receptor NCR1
- (2014) Josh Crouse et al. IMMUNITY
- Interferon- Induces Loss of Spherogenicity and Overcomes Therapy Resistance of Glioblastoma Stem Cells
- (2014) C. Happold et al. MOLECULAR CANCER THERAPEUTICS
- Aging-induced type I interferon response at the choroid plexus negatively affects brain function
- (2014) K. Baruch et al. SCIENCE
- STING Contributes to Antiglioma Immunity via Triggering Type I IFN Signals in the Tumor Microenvironment
- (2014) T. Ohkuri et al. Cancer Immunology Research
- Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake
- (2013) William A Flavahan et al. NATURE NEUROSCIENCE
- Type I Interferons as Stimulators of DC-Mediated Cross-Priming: Impact on Anti-Tumor Response
- (2013) Giovanna Schiavoni et al. Frontiers in Immunology
- A Pilot Study of IL-2Rα Blockade during Lymphopenia Depletes Regulatory T-cells and Correlates with Enhanced Immunity in Patients with Glioblastoma
- (2012) John H. Sampson et al. PLoS One
- Direct Effects of Type I Interferons on Cells of the Immune System
- (2011) S. Hervas-Stubbs et al. CLINICAL CANCER RESEARCH
- TGF- downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients
- (2011) C. A. Crane et al. NEURO-ONCOLOGY
- Targeted delivery of interferon-alpha via fusion to anti-CD20 results in potent antitumor activity against B-cell lymphoma
- (2010) C. Xuan et al. BLOOD
- Role of Type 1 IFNs in Antiglioma Immunosurveillance--Using Mouse Studies to Guide Examination of Novel Prognostic Markers in Humans
- (2010) M. Fujita et al. CLINICAL CANCER RESEARCH
- Tumor-Targeted Interferon-α Delivery by Tie2-Expressing Monocytes Inhibits Tumor Growth and Metastasis
- (2008) Michele De Palma et al. CANCER CELL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More